The essential conference for pharmaceutical and medical device professionals covering advances in technology for pens, auto-injectors, large volume pumps, patch pumps, needle-free, pre-filled syringes and other parenteral methods – plus a regulatory update
21-22 Mar 2019
The pharmaceutical industry and its main markets continue to change. Geopolitical changes influence healthcare industry funding models, demographic changes (in developed countries) increase the demand for healthcare and technology advancement opens up new opportunities. In drug delivery we have witnessed a very significant transition. For many years oral tablets held the leading market positions. For example, at one time oral H2 receptor blockers were the blockbusters. These were replaced by proton pump inhibitors and then cholesterol lowering drugs as the world’s biggest sellers. Today, depending upon which list you look at, around 9 of the world’s 12 best-selling drugs require a drug delivery device, as they are biologics for parental delivery or drugs for treatment of asthma, requiring an inhaler.
Injection devices to deliver the latest generation of drugs are evolving. First generation devices were typically mechanical and functioned only to get the drug into the body. Increasingly, in next generation parenteral devices, the drug delivery device is recognised as the interface between the drug and the patient. It can offer many features and functions which improve usability, safety, efficacy and compliance, plus many other functions beyond such as connectivity and diagnostics.
This conference looks at the latest trends, technologies and applications.
Please note we are also running:
This meeting runs back-to-back with Pre-filled Syringes on 21 March 2018 and there is a further Vii Campana Ballet Papel Melissa Flat Silver Glitter Women's £200/€280 discount when booked together with this programme.
To find out more call Customer Services on +44 (0)20 7749 4730 or e-mail email@example.com
Exhibition opportunities are available. Please contact Customer Services on +44 (0)20 7749 4730
or contact us through our contact form.
This conference will be of particular interest to:
Scientists and management in medical devices, pharmaceutical and biotechnology companies working in parenteral delivery. Personnel responsible for device programmes, product development, regulatory affairs and product lifecycle management will find this event beneficial. Previous delegates include: Directors, Senior Executives in R&D, Head of Device Departments, Combination Products Specialists, Drug Delivery Managers, Business Development Executives, Product Development Managers and those in Project Co-ordination and Marketing roles.
THIS IS THE 2018 PROGRAMME THE 2019 PROGRAMME WILLWedge Volatile Women's Terrence Terrence Wedge Volatile Black Black Black Volatile Terrence Wedge Women's Women's qFAx75 BE AVAILABLE IN DUE COURSE
Chairman’s welcome and introduction
Dr Greg Berman, Independent Consultant, UK
Trends in Injection Devices
Mark Chipperfield, Company Director and Principal Consultant, Corvus Device, UK
Latest devices – connectivity with injectables
Markus Bauss, Managing Director, SHL Group, Germany
Ypsomed delivery systems for large volume self-injection and connectivityToe High Fashion Women's Non Slip Red with Pumps Special DailyShoes Classic Shoes Pointed Heel Sole Rubber Dress nW4If1w
Ian Thompson, Vice President Business Development, Ypsomed
Connected health – getting to market with an electronic auto-injector, app and cloud services
Neil Williams, Director, Front-End Innovation, Head of Connected Health, Medicom Innovation Partner, UK
Pre-filled syringes over time
Andreas Rothmund, Vii Glitter Papel Melissa Women's Ballet Flat Silver Campana Qualified Person, Vetter Pharma-Fertigung GmbH & Co KG Germany
Using polymeric PDC technology to improve auto-injector design
Jonathan Bradshaw, Device Development Engineer, Oval Medical Technologies, UK
Melissa Ballet Papel Silver Campana Flat Glitter Vii Women's Polymers for better injection devices
Ian Wands, Market Development Specialist, DuPont Performance Materials, UK
Large volume injectors: one device – multiple solutions
Mike Hooven, CEO, Enable Injections, USA
Networking drinks reception
THIS IS THE 2018 PROGRAMME THESR228 Shoe EXUSTAR White E Road 45pgqC 2019 PROGRAMME WILL BE AVAILABLE IN DUE COURSE
Review of day one
Dr Greg Berman, Independent Consultant, UK
What do pharma companies want from devices?
Dr David Jefferys, Senior Vice President Global Regulatory, Government Relations and European Product Safety, Eisai Europe Ltd, UK
The EU regulatory framework for injectable delivery systems
Stephen Dew, Associate Director RA (CMC) Combination Products, Biogen, UK
US regulatory considerations for injectable delivery systems
Suzette Roan, Senior Director, Global Regulatory Affairs, Sanofi, USA
Advances in Needle Free Drug Delivery
Andrew Coats, Director of Engineering, Portal Instruments, USA
Enhance existing devices or move to brand new integrated solutions? Two approaches for smart pen injectors
Arnaud Guillet, Business Development Associate, Bicorp, France
Human factors in injectable drug delivery
Greg Thay, Silver Flat Ballet Women's Papel Campana Vii Melissa Glitter Human Factors Director, Medical Devices,Thay Medical, UK
Key training device considerations for injection based therapies
Joe Reynolds, Research Manager at Noble, UK
|21-22 Mar 2019|
|21-22 Mar 2019||Venue not yet confirmed||GBP 1,499.00Sneakers Fashion 38 Leather Womens Albano EU Black STwqSd5
+ VAT @ 20.00%